Brief: SOBI, Enable Injections Announce Development and Distribution Agreement
Sept 12 (Reuters) - Swedish Orphan Biovitrum AB (publ)
SOBIV.ST :
* SOBI® AND ENABLE INJECTIONS ANNOUNCE AGREEMENT TO DEVELOP
AND
DISTRIBUTE ASPAVELI® IN COMBINATION WITH ENFUSE® IN SOBI
TERRITORIES
Source text for Eikon: ID:nWkr4Gc1vJ
Further company coverage: SOBIV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM